Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

Pfizer Inc. (NYSE:PFE)

Paying users zone. Data is hidden behind: .

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey
Unlock

This is a one-time payment. There is no automatic renewal.

Pfizer Inc. pages available today for free:

Adjustments to Financial Statements

Advanced level

Adjustments to Current Assets

Pfizer Inc., adjusted current assets

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Current assets
Adjustments
Add: Allowance for doubtful accounts
After Adjustment
Adjusted current assets

Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).

Adjustments to Total Assets

Pfizer Inc., adjusted total assets

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Total assets
Adjustments
Add: Operating lease right-of-use asset (before adoption of FASB Topic 842)1
Add: Allowance for doubtful accounts
Less: Noncurrent deferred tax assets (included in Noncurrent deferred tax assets and other noncurrent tax assets)2
After Adjustment
Adjusted total assets

Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).

1 Operating lease right-of-use asset (before adoption of FASB Topic 842). See details »

2 Noncurrent deferred tax assets (included in Noncurrent deferred tax assets and other noncurrent tax assets). See details »

Adjustments to Current Liabilities

Pfizer Inc., adjusted current liabilities

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Current liabilities
Adjustments
Less: Current restructuring accruals
After Adjustment
Adjusted current liabilities

Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).

Adjustments to Total Liabilities

Pfizer Inc., adjusted total liabilities

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Total liabilities
Adjustments
Add: Operating lease liability (before adoption of FASB Topic 842)1
Less: Noncurrent deferred tax liabilities2
Less: Restructuring accruals
After Adjustment
Adjusted total liabilities

Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Noncurrent deferred tax liabilities. See details »

Adjustments to Stockholders’ Equity

Pfizer Inc., adjusted total Pfizer Inc. shareholders’ equity

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Total Pfizer Inc. shareholders’ equity
Adjustments
Less: Net deferred tax asset (liability)1
Add: Allowance for doubtful accounts
Add: Restructuring accruals
Add: Equity attributable to noncontrolling interests
After Adjustment
Adjusted total equity

Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).

1 Net deferred tax asset (liability). See details »

Adjustments to Capitalization Table

Pfizer Inc., adjusted capitalization table

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Short-term borrowings, including current portion of long-term debt
Long-term debt, excluding current portion
Total reported debt
Total Pfizer Inc. shareholders’ equity
Total reported capital
Adjustments to Debt
Add: Operating lease liability (before adoption of FASB Topic 842)1
Add: Operating lease liabilities, short-term (included in Other current liabilities)2
Add: Operating lease liabilities, long-term (included in Other noncurrent liabilities)3
Adjusted total debt
Adjustments to Equity
Less: Net deferred tax asset (liability)4
Add: Allowance for doubtful accounts
Add: Restructuring accruals
Add: Equity attributable to noncontrolling interests
Adjusted total equity
After Adjustment
Adjusted total capital

Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).

1 Operating lease liability (before adoption of FASB Topic 842). See details »

2 Operating lease liabilities, short-term (included in Other current liabilities). See details »

3 Operating lease liabilities, long-term (included in Other noncurrent liabilities). See details »

4 Net deferred tax asset (liability). See details »

Adjustments to Reported Income

Pfizer Inc., adjusted net income attributable to Pfizer Inc.

US$ in millions

Microsoft Excel LibreOffice Calc
12 months ended: Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
As Reported
Net income attributable to Pfizer Inc.
Adjustments
Add: Deferred income tax expense (benefit)1
Add: Increase (decrease) in allowance for doubtful accounts
Add: Increase (decrease) in restructuring accruals
Less: Discontinued operations, net of tax
Add: Other comprehensive income (loss) before allocation to noncontrolling interests
Add: Comprehensive income (loss), net of tax, attributable to noncontrolling interest
After Adjustment
Adjusted net income before allocation to noncontrolling interests

Based on: 10-K (filing date: 2020-02-27), 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29).

1 Deferred income tax expense (benefit). See details »